118 related articles for article (PubMed ID: 9150287)
21. Opioid systems in the response to inflammatory pain: sustained blockade suggests role of kappa- but not mu-opioid receptors in the modulation of nociception, behaviour and pathology.
Millan MJ; Colpaert FC
Neuroscience; 1991; 42(2):541-53. PubMed ID: 1654538
[TBL] [Abstract][Full Text] [Related]
22. Dynorphin-(1-13): antinociceptive action and its effects on morphine analgesia and acute tolerance.
Kishioka S; Morita N; Kitabata Y; Yamanishi T; Miyamoto Y; Ozaki M; Yamamoto H
Jpn J Pharmacol; 1992 Nov; 60(3):197-207. PubMed ID: 1362787
[TBL] [Abstract][Full Text] [Related]
23. Antinociceptive activity of eel calcitonin, injected into the inflamed paw in rats.
Guidobono F; Netti C; Villani P; Bettica P; Pecile A
Neuropharmacology; 1991 Dec; 30(12A):1275-8. PubMed ID: 1787881
[TBL] [Abstract][Full Text] [Related]
24. Antinociceptive effects of meptazinol and its isomers on carrageenan-induced thermal hyperalgesia in rats.
Wang PF; Zhang YQ; Qiu ZB; Zhao ZQ
Sheng Li Xue Bao; 2004 Jun; 56(3):295-300. PubMed ID: 15224140
[TBL] [Abstract][Full Text] [Related]
25. Methionine-enkephalin-and Dynorphin A-release from immune cells and control of inflammatory pain.
Cabot PJ; Carter L; Schäfer M; Stein C
Pain; 2001 Sep; 93(3):207-212. PubMed ID: 11514079
[TBL] [Abstract][Full Text] [Related]
26. Suppression by dynorphin A and [des-Tyr1]dynorphin A peptides of the expression of opiate withdrawal and tolerance in morphine-dependent mice.
Takemori AE; Loh HH; Lee NM
J Pharmacol Exp Ther; 1993 Jul; 266(1):121-4. PubMed ID: 8101214
[TBL] [Abstract][Full Text] [Related]
27. Spinal opioid analgesic effects are enhanced in a model of unilateral inflammation/hyperalgesia: possible involvement of noradrenergic mechanisms.
Hylden JL; Thomas DA; Iadarola MJ; Nahin RL; Dubner R
Eur J Pharmacol; 1991 Mar; 194(2-3):135-43. PubMed ID: 1676373
[TBL] [Abstract][Full Text] [Related]
28. The central versus peripheral antinociceptive effects of μ-opioid receptor agonists in the new model of rat visceral pain.
Al-Khrasani M; Lackó E; Riba P; Király K; Sobor M; Timár J; Mousa S; Schäfer M; Fürst S
Brain Res Bull; 2012 Feb; 87(2-3):238-43. PubMed ID: 22079588
[TBL] [Abstract][Full Text] [Related]
29. Peripheral effect of fentanyl upon nociception in inflamed tissue of the rat.
Stein C; Millan MJ; Shippenberg TS; Herz A
Neurosci Lett; 1988 Jan; 84(2):225-8. PubMed ID: 3340329
[TBL] [Abstract][Full Text] [Related]
30. Peripherally mediated antinociception of the mu-opioid receptor agonist 2-[(4,5alpha-epoxy-3-hydroxy-14beta-methoxy-17-methylmorphinan-6beta-yl)amino]acetic acid (HS-731) after subcutaneous and oral administration in rats with carrageenan-induced hindpaw inflammation.
Bileviciute-Ljungar I; Spetea M; Guo Y; Schütz J; Windisch P; Schmidhammer H
J Pharmacol Exp Ther; 2006 Apr; 317(1):220-7. PubMed ID: 16339394
[TBL] [Abstract][Full Text] [Related]
31. Behavioural evidence for a peripheral component in the enhanced antinociceptive effect of a low dose of systemic morphine in carrageenin-induced hyperalgesic rats.
Kayser V; Chen YL; Guilbaud G
Brain Res; 1991 Sep; 560(1-2):237-44. PubMed ID: 1760731
[TBL] [Abstract][Full Text] [Related]
32. Antinociceptive effects of mu- and kappa-agonists in inflammation are enhanced by a peripheral opioid receptor-specific mechanism.
Stein C; Millan MJ; Yassouridis A; Herz A
Eur J Pharmacol; 1988 Oct; 155(3):255-64. PubMed ID: 2853065
[TBL] [Abstract][Full Text] [Related]
33. Analgesic effects of mu-, delta- and kappa-opiate agonists and, in particular, dynorphin at the spinal level.
Przewłocki R; Stala L; Greczek M; Shearman GT; Przewłocka B; Herz A
Life Sci; 1983; 33 Suppl 1():649-52. PubMed ID: 6141505
[TBL] [Abstract][Full Text] [Related]
34. Evidence for a central long-lasting antinociceptive effect of vapreotide, an analog of somatostatin, involving an opioidergic mechanism.
Betoin F; Ardid D; Herbet A; Aumaitre O; Kemeny JL; Duchene-Marullaz P; Lavarenne J; Eschalier A
J Pharmacol Exp Ther; 1994 Apr; 269(1):7-14. PubMed ID: 7909563
[TBL] [Abstract][Full Text] [Related]
35. Peripheral effects of the kappa-opioid agonist EMD 61753 on pain and inflammation in rats and humans.
Machelska H; Pflüger M; Weber W; Piranvisseh-Völk M; Daubert JD; Dehaven R; Stein C
J Pharmacol Exp Ther; 1999 Jul; 290(1):354-61. PubMed ID: 10381799
[TBL] [Abstract][Full Text] [Related]
36. Competitive and non-competitive NMDA antagonists block the development of antinociceptive tolerance to morphine, but not to selective mu or delta opioid agonists in mice.
Bilsky EJ; Inturrisi CE; Sadée W; Hruby VJ; Porreca F
Pain; 1996 Dec; 68(2-3):229-37. PubMed ID: 9121809
[TBL] [Abstract][Full Text] [Related]
37. Antinociception and paralysis induced by intrathecal dynorphin A.
Herman BH; Goldstein A
J Pharmacol Exp Ther; 1985 Jan; 232(1):27-32. PubMed ID: 2856940
[TBL] [Abstract][Full Text] [Related]
38. Differential antinociceptive effects induced by intrathecally administered endomorphin-1 and endomorphin-2 in the mouse.
Sakurada S; Hayashi T; Yuhki M; Orito T; Zadina JE; Kastin AJ; Fujimura T; Murayama K; Sakurada C; Sakurada T; Narita M; Suzuki T; Tan-no K; Tseng LF
Eur J Pharmacol; 2001 Sep; 427(3):203-10. PubMed ID: 11567650
[TBL] [Abstract][Full Text] [Related]
39. [Peripheral analgesic actions of opioid peptides and morphine analogues].
Shibata M; Ohkubo T; Takahashi H; Kudo T; Inoki R
Nihon Yakurigaku Zasshi; 1986 Aug; 88(2):101-7. PubMed ID: 2876930
[TBL] [Abstract][Full Text] [Related]
40. Production of antinociception by peripheral administration of [Lys7]dermorphin, a naturally occurring peptide with high affinity for mu-opioid receptors.
Negri L; Lattanzi R; Melchiorri P
Br J Pharmacol; 1995 Jan; 114(1):57-66. PubMed ID: 7712029
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
